Literature DB >> 19579885

[Retrospective evaluation of urinary continence in patients submitted to brachytherapy after transurethral resection of the prostate gland].

Daniel Ramirez Claros1, João Antonio Pereira Correia, Luiz Renato Muglia Ferreira, Fernando Pires Vaz.   

Abstract

INTRODUCTION AND
OBJECTIVE: Some candidates for brachytherapy present with a previous history of prostate transurethral resection (TURP). Nonetheless, TURP generates a cavity that may lead to technical difficulties in performing brachytherapy. Such condition make a history of previous TURP a relative contra-indication for brachytherapy. The aim of this study is to evaluate the role of brachytherapy in urinary continence, in a group of patients with previous history of TURP.
MATERIALS AND METHODS: In our study, we analysed a group of 16 patients submitted to TURP pre-brachytherapy. The mean quality of life score from ICSmaleSF questionnaire ranged from 0 to 1 before and after brachytheraphy (average: 0,18 -- before; average: 0,20 -- after). There was no estatistically significant difference between the former values (p<0,001). After brachytherapy patients were evaluated for lower urinary tract symptoms. The time interval between TURP and brachytherapy ranged from 30 to 90 days (average: 60 days). Post-brachytherapy follow-up varied between 3 and 60 months (average: 30 months).
RESULTS: None of the 16 patients evaluated presented lower urinary tract symptoms nor urinary incontinence. Medical complications observed in patients were: dysuria, erectile dysfunction, scrotal ecchymosis and urinary retention. The cases of dysuria, scrotal ecchymosis and urinary retention observed were of short-duration, the last one with spontaneous resolution after 7 days of vesical catheterism. The patient presenting erectile dysfunction had a good response to oral type 5 fosfodiesterase inhibitor three times a week, after a six month period.
CONCLUSION: In accordance with other studies, we believe that with some strategy TURP should not be considered a relative contra-indication for brachytherapy.

Entities:  

Mesh:

Year:  2009        PMID: 19579885     DOI: 10.1016/s0210-4806(09)74160-9

Source DB:  PubMed          Journal:  Actas Urol Esp        ISSN: 0210-4806            Impact factor:   0.994


  2 in total

1.  Low-dose-rate brachytherapy for patients with transurethral resection before implantation in prostate cancer. Longterm results.

Authors:  Pedro J Prada; Javier Anchuelo; Ana Garcia Blanco; Gema Paya; Juan Cardenal; Enrique Acuna; Maria Ferri; Andres Vazquez; Maite Pacheco; Jesica Sanchez
Journal:  Int Braz J Urol       Date:  2016 Jan-Feb       Impact factor: 1.541

2.  A history of transurethral resection of the prostate should not be a contra-indication for low-dose-rate 125I prostate brachytherapy: results of a prospective Uro-GEC phase-II trial.

Authors:  Carl Salembier; Ann Henry; Bradley R Pieters; Peter Hoskin
Journal:  J Contemp Brachytherapy       Date:  2020-02-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.